These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery. Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460 [TBL] [Abstract][Full Text] [Related]
6. Lipid-based Nanocarriers for siRNA Delivery: Challenges, Strategies and the Lessons Learned from the DODAX: MO Liposomal System. Oliveira ACN; Fernandes J; Gonçalves A; Gomes AC; Oliveira MECDR Curr Drug Targets; 2019; 20(1):29-50. PubMed ID: 29968536 [TBL] [Abstract][Full Text] [Related]
7. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery. Gujrati M; Vaidya A; Lu ZR Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982 [TBL] [Abstract][Full Text] [Related]
8. Non-viral nucleic acid containing nanoparticles as cancer therapeutics. Kozielski KL; Rui Y; Green JJ Expert Opin Drug Deliv; 2016 Oct; 13(10):1475-87. PubMed ID: 27248202 [TBL] [Abstract][Full Text] [Related]
9. A review of nanocarriers for the delivery of small interfering RNA. Kesharwani P; Gajbhiye V; Jain NK Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160 [TBL] [Abstract][Full Text] [Related]
10. Stimuli-sensitive nanopreparations for combination cancer therapy. Jhaveri A; Deshpande P; Torchilin V J Control Release; 2014 Sep; 190():352-70. PubMed ID: 24818767 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in siRNA delivery for cancer therapy using smart nanocarriers. Zhang P; An K; Duan X; Xu H; Li F; Xu F Drug Discov Today; 2018 Apr; 23(4):900-911. PubMed ID: 29373841 [TBL] [Abstract][Full Text] [Related]
12. Multi-compartmental oral delivery systems for nucleic acid therapy in the gastrointestinal tract. Kriegel C; Attarwala H; Amiji M Adv Drug Deliv Rev; 2013 Jun; 65(6):891-901. PubMed ID: 23220324 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-siRNA: A potential cancer therapy? Young SW; Stenzel M; Yang JL Crit Rev Oncol Hematol; 2016 Feb; 98():159-69. PubMed ID: 26597018 [TBL] [Abstract][Full Text] [Related]
14. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges. Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781 [TBL] [Abstract][Full Text] [Related]
15. Attacking the genome: emerging siRNA nanocarriers from concept to clinic. Alabi C; Vegas A; Anderson D Curr Opin Pharmacol; 2012 Aug; 12(4):427-33. PubMed ID: 22726555 [TBL] [Abstract][Full Text] [Related]